<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10424739</article-id><article-id pub-id-type="pmc">2363072</article-id><article-id pub-id-type="pii">6690532</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690532</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Oral topotecan: bioavailability and effect of food co-administration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Herben</surname><given-names>V M M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rosing</surname><given-names>H</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Huinink</surname><given-names>W W ten Bokkel</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zomeren</surname><given-names>D M van</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Batchelor</surname><given-names>D</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Doyle</surname><given-names>E</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Beusenberg</surname><given-names>F D</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Beijnen</surname><given-names>J H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schellens</surname><given-names>J H M</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands</aff><aff id="aff2"><label>2</label>Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands</aff><aff id="aff3"><label>3</label>Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals, Hertfordshire, UK</aff><aff id="aff4"><label>4</label>SmithKline Beecham Farma, Rijswijk, The Netherlands</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: </corresp></author-notes><pub-date pub-type="ppub"><month>07</month><year>1999</year></pub-date><volume>80</volume><issue>9</issue><fpage>1380</fpage><lpage>1386</lpage><history><date date-type="received"><day>10</day><month>06</month><year>1998</year></date><date date-type="rev-recd"><day>08</day><month>12</month><year>1998</year></date><date date-type="accepted"><day>21</day><month>01</month><year>1999</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><kwd-group><kwd>topotecan</kwd><kwd>oral</kwd><kwd>bioavailability</kwd><kwd>food</kwd></kwd-group></article-meta></front></article>


